CRISPR Sickle Cell Gene Therapy Shows Durable Early Promise Early CRISPR trial data is fueling hope for sickle cell patients, with 12-month follow-up results suggesting durable gene correction. #CRISPR #SickleCell #GeneTherapy /blog/crispr-sickle-cell-gene-therapy-shows-early-promise